Delivery Order SPE2DB22D2206-SPE2DB25FEG07
Award Date
11/15/24
Potential Completion Date
12/9/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.15 Firm Fixed Price delivery order is for the supply of Pfizer COVID-19 vaccines and related medical products from 2024 to 2025, with a potential performance period of up to 4 years. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,778.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, including 0.9 mL dosages under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price delivery order. There was no set-aside designation...
This federal contract award, valued at $1,622.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines during the 2024-2025 timeframe, including doses ranging from 6 months to 4 years, with a 0.9ML dosage. This award is not designated as a set-aside. Amerisourcebergen Drug Corp maintains an Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,149.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...